{"": [178, 1447, 0, 53624, 53718, 0], "Supplementary Information": [1448, 1567, 0, 53597, 53718, 1], "Introduction": [1568, 5788, 0], "Four groups of neutralizing epitopes on SARS-CoV-2 RBD": [5798, 6511, 0], "Potent and broad neutralizing activity of XG014": [6512, 10379, 0], "Structural analysis of SARS-CoV-2 S-XG014 complex": [10380, 14052, 0], "XG014 has a unique antigen-binding epitope": [14053, 18229, 0], "Antibodies targeting the same epitope group as XG014": [18230, 21177, 0], "Structural comparison between XG005- and XG014-bound SARS-CoV-2 S trimers": [21178, 24639, 0], "Protection and treatment in human ACE2 transgenic mice": [24640, 25971, 0], "Results": [5789, 25971, 1], "DISCUSSION": [25972, 32677, 0], "Cell lines": [32701, 33238, 0], "Antibodies expression": [33239, 33845, 0], "BLI": [33846, 34934, 0], "ELISA and competition ELISA": [34935, 36249, 0], "Generation of pseudotyped viruses": [36250, 38193, 0], "In vitro neutralization assay using pseudotyped viruses": [38194, 39320, 0], "S protein-mediated cell-cell fusion in Huh-7, Caco-2 and Calu-3 cells": [39321, 40330, 0], "Antibody-dependent S protein-mediated cell-cell fusion in Raji cells": [40331, 41438, 0], "In vitro neutralization assay using authentic SARS-CoV-2 virus": [41439, 42710, 0], "Plaque reduction assay": [42711, 43430, 0], "Expression and purification of SARS-CoV-2 S trimer": [43431, 44301, 0], "Cryo-EM sample preparation and data collection": [44302, 46045, 0], "Data processing of SARS-CoV-2 S-XG014 complex": [46046, 47364, 0], "Data processing of SARS-CoV-2 S-XG005 complex": [47365, 50294, 0], "Model building and structure refinement": [50295, 51625, 0], "Human ACE2 transgenic mice and in vivo studies": [51626, 53073, 0], "Statistical analysis": [53074, 53596, 0], "Materials and methods": [32678, 53596, 1]}